Spontaneous behaviours of rats are differentially affected by substantia nigra infusions of brain-derived neurotrophic factor and neurotrophin-3

European Journal of Neuroscience

Volumn 8, Issue 8, 1996, Pages 1696-1706

  Martin lverson, Mathew T ^a   Altar, C Anthony ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Dopamine; Growth factors; Rat; Serotonin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; NEUROTROPHIN; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; APPETITE; ARTICLE; BODY POSTURE; BODY WEIGHT; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRINKING; EXPLORATORY BEHAVIOR; FEEDING; FOOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBSTANTIA NIGRA; WEIGHT REDUCTION;

EID: 0029739699     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.1996.tb01313.x     Document Type: Article

References (28)

1. Altar, C. A., Boylan, C. B., Jackson, C., Hershenson, S., Miller, G., Wiegand, S. J., Lindsay, R. M. and Hyman, C. (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl Acad. Sci. USA, 89, 11347-11351.
2. 125I]neurotrophin-3 binding to mammalian brain. J. Neurosci., 13, 733-743.
3. Altar, C. A., Boylan, C. B., Fritsche, M., Jones, B. E., Jackson, C., Hyman, C. and Lindsay, R. M. (1994a) The neurotrophins N-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp. Neurol., 130, 31-40.
4. Altar, C. A., Boylan, C. B., Pritsche, M., Jones, B. E., Jackson, C, Wiegand, S. J., Lindsay, R. M. and Hyman, C. (1994b) Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigroslriatal dopamine lesions. J. Neurochem., 63, 1021-1032.
5. 125I]NT-3. Eur. J. Neurosci., 6, 1389-1405.
6. Altar, C. A., Wiegand, S. J., Lindsay, R. M. and Cedarbaum, J. M. (1996) Neurotrophic factors: towards a restorative pharmacology of Parkinson's disease. In Olanow, C. W., Jenner, P. and Youdim, M. (eds), Neuroprotective Approaches to the Treatment of Neurodegenerative Diseases. Academic Press, London, in press.
7. Andrews, C. D., Fernando, J. C. R. and Curzon, G. (1982) Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses. Neuropharmacology, 21, 63-68.
8. Arenas, E., Ǎkerud, P., Wong, V., Boylan, C. B., Persson, H., Lindsay, R. M. and Altar, C. A. (1996) Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo. Eur. J. Neurosci., 8, 1707-1717.
9. Curzon, G. (1990) Stereotyped and other responses to 5-hydroxytryptamine receptor activation. In Cooper, S. J. (ed.), Neurobiology of Stereotyped Behaviour. Oxford University Press, London, pp. 142-168.
10. Dourish, C. T. (1984) Studies on the mechanism of action of β-phenylethylamine animal model of schizophrenia. In Boulton, A. A., Baker, G. B., Dewhurst, W. G. and Sandler, M. (eds), Neurobiology of the Trace Amines. Humana Press, Clifton, NJ, pp. 389-411.
11. Frim, D. M., Uhler, T. A., Galpern, W. R., Beal, M. F., Breakfield, X. O. and Isaacson, O. (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl Acad. Sci. USA, 91, 5104-5108.
12. Greidanus, T. B. V. W., Van de Brug, F., De Bruijckere, L. M., Pabst, P. H. M. A., Ruesink, R. W., Hulshof, R. L. E., Van Berckel, B. N. M., Arissen, S. M., De Koning, E. J. P. and Donker, D. K. (1988) Comparison of bombesin-, ACTH-, and β-endorphin-induced grooming. In Colbern, D. L. and Gispen, W. H. (eds), Neural Mechanisms and Biological Significance of Grooming Behavior. Ann. N.Y. Acad. Sci., 525, 219-227.
13. Hagg, T. (1994) Neurotrophins (BDNF, NT-3, NT-4) prevent death of axotomized adult rat substantia nigra neurons. Soc. Neurosci. Abstr., 20, 441.
14. Lamballe, F., Klein, R. and Barbacid, M. (1991) trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell, 66, 967-979.
15. Lindsay, R. M., Altar, C. A., Cedarbaum, J. M., Hyman, C., Wiegand, S. J., (1993) The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp. Neurol., 124, 103-118.
16. Marshall, J. F. (1979) Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control. Brain Res., 177, 311-324.
17. Marshall, J. F. and Gotthelf, T. (1979) Sensory inattention in rats with 6hydroxydopamine-induced degeneration of ascending dopaminergic neurons: apomorphine-induced reversal of deficits. Exp Neurol., 65, 398-411.
18. Martin-Iverson, M. T. (1991) An animal model of stimulant psychoses. In Boulton, A. A., Baker, G. B. and Martin-Iverson, M. T. (eds), Neuromethods: Animal Models in Psychiatry I, Vol. 18. Humana Press, Clifton, NJ, pp. 103-149.
19. Martin-Iverson, M. T. and Dourish, C. T. (1988) Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats. Psychopharmacology, 96, 370-374.
20. Martin-Iverson, M. T., Todd, K. G. and Altar, C. A. (1994) Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J. Neurosci., 14, 1262-1270.
21. 2 receptor agonists and antagonists on bombesin-induced behaviors. Eur. J. Pharmacol., 191, 281-293.
22. Merchant, K. M., Letter, A. A., Gibb, J. W. and Hanson, G. R. (1988) Changes in the limbic neurotensin systems induced by dopaminergic drugs. Eur. J. Pharmacol., 153, 1-9.
23. Pau, C., Siuciak, J. A., Tran, T. M., Altar, C. A. and Tepper, J. M (1996). Infusion of BDNF modifies the firing pattern of dorsal raphe serotonergic neurons. Brain Res., 712, 293-298.
24. Piggins, H. and Merali, Z. (1989) The effects of concurrent D-1 and D-2 dopamine receptor blockade with SCH 23390 and eticlopride, on bombesin-induced behaviours. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 13, 583-594.
25. Scheel-Krüger, J. (1972) Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic antidepressant drugs. Eur. J. Pharmacol., 18, 63-73.
26. Shen, R.-Y, Altar, C. A. and Chiodo, L. A. (1994) Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc. Natl Acad. Sci. USA, 91, 8920-8924.
27. Siuciak, J. A., Altar, C. A., Wiegand, S. J. and Lindsay, R. M. (1994) Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res., 633, 326-330.
28. Siuciak, J. S., Boylan, C., Fritsche, M., Attar, C. A. and Lindsay, R. M. (1996) BDNF increases monoaminergic activity in rat brain following intraventricular or intraparenchymal administration. Brain Res., 710, 11-20.